These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

79 related items for PubMed ID: 7772651

  • 1. Serotonergic responsivity in trichotillomania: neuroendrocrine effects of m-chlorophenylpiperazine.
    Stein DJ, Hollander E, Cohen L, Simeon D, Aronowitz B.
    Biol Psychiatry; 1995 Mar 15; 37(6):414-6. PubMed ID: 7772651
    [No Abstract] [Full Text] [Related]

  • 2. Effect of serum cholesterol levels on meta-chlorophenylpiperazine-evoked neuroendocrine responses in healthy subjects.
    Terao T, Yoshimura R, Ohmori O, Takano T, Takahashi N, Iwata N, Suzuki T, Abe K.
    Biol Psychiatry; 1997 May 01; 41(9):974-8. PubMed ID: 9110103
    [Abstract] [Full Text] [Related]

  • 3. Heterogeneity of serotonergic response in treatment-refractory schizophrenia patients.
    Lindenmayer JP, Adityanjee, Vital-Herne M, Bark N, Grochowski S, Moynihan N.
    Biol Psychiatry; 1997 Jul 01; 42(1):6-12. PubMed ID: 9193736
    [Abstract] [Full Text] [Related]

  • 4. Estrogen augments serotonergic activity in postmenopausal women.
    Halbreich U, Rojansky N, Palter S, Tworek H, Hissin P, Wang K.
    Biol Psychiatry; 1995 Apr 01; 37(7):434-41. PubMed ID: 7786956
    [Abstract] [Full Text] [Related]

  • 5. Hormonal, psychological, and alcohol craving changes after m-chlorophenylpiperazine administration in alcoholics.
    Buydens-Branchey L, Branchey M, Fergeson P, Hudson J, McKernin C.
    Alcohol Clin Exp Res; 1997 Apr 01; 21(2):220-6. PubMed ID: 9113256
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics of m-chlorophenylpiperazine after intravenous and oral administration in healthy male volunteers: implication for the pharmacodynamic profile.
    Feuchtl A, Bagli M, Stephan R, Frahnert C, Kölsch H, Kühn KU, Rao ML.
    Pharmacopsychiatry; 2004 Jul 01; 37(4):180-8. PubMed ID: 15467976
    [Abstract] [Full Text] [Related]

  • 7. Neuroendocrine and behavioral responses to intravenous m-chlorophenylpiperazine (mCPP) in depressed patients and healthy comparison subjects.
    Anand A, Charney DS, Delgado PL, McDougle CJ, Heninger GR, Price LH.
    Am J Psychiatry; 1994 Nov 01; 151(11):1626-30. PubMed ID: 7943451
    [Abstract] [Full Text] [Related]

  • 8. Anxiogenic effects of m-CPP in patients with panic disorder: comparison to caffeine's anxiogenic effects.
    Klein E, Zohar J, Geraci MF, Murphy DL, Uhde TW.
    Biol Psychiatry; 1991 Nov 15; 30(10):973-84. PubMed ID: 1756202
    [Abstract] [Full Text] [Related]

  • 9. Evidence for a decline with age in behavioral responsivity to the serotonin agonist, m-chlorophenylpiperazine, in healthy human subjects.
    Lawlor BA, Sunderland T, Hill JL, Mellow AM, Molchan SE, Mueller EA, Jacobsen FM, Murphy DL.
    Psychiatry Res; 1989 Jul 15; 29(1):1-10. PubMed ID: 2772095
    [Abstract] [Full Text] [Related]

  • 10. Ethanol substitutes for the discriminative stimulus effects of m-chlorophenylpiperazine.
    Gatch MB.
    Brain Res; 2005 Nov 16; 1062(1-2):161-5. PubMed ID: 16256082
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Neuroendocrine effects of M-chlorophenylpiperazine, a serotonin agonist, in humans.
    Mueller EA, Murphy DL, Sunderland T.
    J Clin Endocrinol Metab; 1985 Dec 16; 61(6):1179-84. PubMed ID: 4055985
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Serotonergic function in obsessive-compulsive disorder. Behavioral and neuroendocrine responses to oral m-chlorophenylpiperazine and fenfluramine in patients and healthy volunteers.
    Hollander E, DeCaria CM, Nitescu A, Gully R, Suckow RF, Cooper TB, Gorman JM, Klein DF, Liebowitz MR.
    Arch Gen Psychiatry; 1992 Jan 16; 49(1):21-8. PubMed ID: 1728249
    [Abstract] [Full Text] [Related]

  • 16. Serotonin function in schizophrenia: effects of meta-chlorophenylpiperazine in schizophrenic patients and healthy subjects.
    Kahn RS, Siever LJ, Gabriel S, Amin F, Stern RG, DuMont K, Apter S, Davidson M.
    Psychiatry Res; 1992 Jul 16; 43(1):1-12. PubMed ID: 1332094
    [Abstract] [Full Text] [Related]

  • 17. Responses to mCPP stimulation in depressed patients.
    Thakore JH.
    Am J Psychiatry; 1995 Dec 16; 152(12):1833-4; author reply 1834-5. PubMed ID: 8526261
    [No Abstract] [Full Text] [Related]

  • 18. Plasma levels of m-chlorophenylpiperazine following single oral dose administration of m-chlorophenylpiperazine and trazodone in human volunteers.
    Lawlor BA, Radcliffe J, Martinez R, Sunderland T, Murphy DL.
    Biol Psychiatry; 1997 Mar 15; 41(6):756-7. PubMed ID: 9067003
    [No Abstract] [Full Text] [Related]

  • 19. Hormonal and temperature responses to the 5-HT1A receptor agonist flesinoxan in normal volunteers.
    Pitchot W, Wauthy J, Hansenne M, Pinto E, Fuchs S, Reggers J, Legros JJ, Ansseau M.
    Psychopharmacology (Berl); 2002 Oct 15; 164(1):27-32. PubMed ID: 12373416
    [Abstract] [Full Text] [Related]

  • 20. Hormonal responses to meta-chlorophenylpiperazine (m-CPP) are undiminished by acute m-CPP pretreatment.
    Coccaro EF, Kavoussi RJ, Trestman RL, Gabriel SM, Cooper TB, Siever LJ.
    Psychiatry Res; 1996 May 17; 62(2):139-45. PubMed ID: 8771611
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.